Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Enfamil Lipil infant formula outperforms Similac Advance when it comes to a child’s mental and visual impairment, according to Enfamil’s advertising claims.
However, the National Advertising Division of the Better Business Bureau doesn’t agree. The advertising industry’s self-regulatory forum has taken issue with these claims which have appeared in print ads, point-of-sale materials as well as on Enfamil Lipil packaging.
Enfamil has also distributed coupons that show a chart inviting consumers to compare the differences between Enfamil Lipil and Abbott Nutrition’s Similac Advance.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in